Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Wayne, Pennsylvania
- Most recent report
- 10-Q, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1534120
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 43
News 8 of 185
Prospectuses and Registrations 8 of 79
- 424B3 Prospectus supplement for an offering Jul 28, 2026
- S-3 Shelf registration statement Jul 17, 2026
- 424B5 Prospectus supplement for an offering May 7, 2026
- 424B5 Prospectus supplement for an offering May 5, 2026
- S-8 Registration statement for an employee plan Mar 23, 2026
- S-3 Shelf registration statement Jan 8, 2026
- S-8 Registration statement for an employee plan Nov 6, 2025
- 424B5 Prospectus supplement for an offering Jun 5, 2025
Proxies 8 of 29
- DEFA14A Extra proxy material Apr 10, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2026
- DEFA14A Extra proxy material May 1, 2025
- DEF 14A Proxy statement for a shareholder vote May 1, 2025
- DEFA14A Extra proxy material Jun 27, 2024
- DEF 14A Proxy statement for a shareholder vote Jun 27, 2024
- PRE 14A Preliminary proxy statement Jun 7, 2024
- DEFA14A Extra proxy material Mar 28, 2024
Ownership 8 of 605
- 4 Insider reported a trade Sep 1, 2026
- 4 Insider reported a trade Aug 19, 2026
- 4 Insider reported a trade Aug 19, 2026
- 144 Notice of a proposed sale of restricted stock Aug 18, 2026
- 144 Notice of a proposed sale of restricted stock Aug 17, 2026
- 144 Notice of a proposed sale of restricted stock Aug 17, 2026
- 144 Notice of a proposed sale of restricted stock Aug 17, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
Other 8 of 59
- EFFECT Notice that a registration became effective Jul 28, 2026
- ARS Annual report sent to shareholders Apr 10, 2026
- EFFECT Notice that a registration became effective Jan 20, 2026
- CORRESP Reply to SEC staff Jan 15, 2026
- UPLOAD Comment letter from SEC staff Jan 14, 2026
- ARS Annual report sent to shareholders May 1, 2025
- UPLOAD Comment letter from SEC staff Aug 6, 2024
- EFFECT Notice that a registration became effective Aug 5, 2024
Everything here comes from Avalo Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.